Project Oncology®

156 Folgen

1. CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer

   Vom: 23.10.2017
2. Pancreatic Cancer: The Hunt to Catch a Silent Killer

   Vom: 12.8.2017
3. FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer

   Vom: 28.7.2017
4. FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer

   Vom: 25.7.2017
5. Linking p53 Variation to Breast Cancer Risk in African American Women

   Vom: 19.6.2017
6. FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval

   Vom: 30.5.2017
7. Pancreatic Cancer: Associated Signs, Symptoms, Risk Factors and Treatment Approaches

   Vom: 23.5.2017
8. FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma

   Vom: 22.5.2017
9. FDA D.I.S.C.O.: Niraparib in Ovarian Cancer

   Vom: 18.5.2017
10. Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer

    Vom: 17.4.2017
11. Hot Topics in Breast Cancer Innovations

    Vom: 6.2.2017
12. A Thoracic Surgeon's Viewpoint on Screening, Diagnosis and Treatment of a Lung Cancer Patient

    Vom: 2.2.2017
13. High Hopes for Cannabis in Oncology: Therapeutic Applications Beyond Pain Management

    Vom: 20.4.2016
14. From Silent Killer to Treatable Disease: Improved Detection Methods for Ovarian Cancer

    Vom: 7.3.2016
15. Are Practicing Ob-Gyn Oncologists on Your Speed Dial?

    Vom: 8.2.2016
16. Nutrition & Breast Cancer Risk: Connecting the Dots with Emerging Evidence

    Vom: 31.8.2015